2 enrolling by invitation. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Enrolling by invitation 2 |
Follow Tauopathies: new trials by email Literature Review of Tauopathies trials Research Report on Tauopathies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study of StudyU for N-of-1 Trials in HFrEF Patients (N-of-1 App) beta blockers, StudyU Application - HFrEF - Heart Failure With Reduced Ejection Fraction, Heart Failure | Phase 4 | Enrolling by invitation | Weill Medical College of Cornell University | 5 | 2026-02-10 | 2026-02-19 |
| Imaging of Brain Amyloid Plaques in the Aging Population Pittsburgh Compound B (C-11 PiB), F-18 FDG, Tau (18-F-AV-1451) - Alzheimer's Disease, Dementia With Lewy Bodies | Phase 4 | Enrolling by invitation | Mayo Clinic | 8000 | 2008-04-01 | 2026-06-23 |
Alzheimer Disease (2) · Dementia (1) · Dementia, Vascular (1) · Frontotemporal Dementia (1) · Heart Diseases (1) · Heart Failure (1) · Heart Failure, Systolic (1) · Lewy Body Disease (1)
Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Mental Disorders (2) · Nervous System Diseases (2) · Neurocognitive Disorders (2) · Neurodegenerative Diseases (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Basal Ganglia Diseases (1) · Cerebrovascular Disorders (1) · Dementia (1) · Frontotemporal Lobar Degeneration (1) · Intracranial Arterial Diseases (1)
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (1) · Adrenergic beta-Antagonists (1) · tau Proteins (1)
Mayo Clinic (1) · Weill Medical College of Cornell University (1)
United States (2)
Parag Goyal, MD, MSc (1) · Val Lowe, M.D. (1)
R01AG011378 (1), U01AG006786 (1)